Elyse klinieken voor nierzorg
- Address
- Smedenstraat 4, 6461 GA Kerkrade, The Netherlands
Elyse Klinieken voor Nierzorg - Advanced Nephrology Research Center
Elyse Klinieken voor Nierzorg is a specialized nephrology research center dedicated to advancing treatment options for patients with advanced chronic kidney disease. The center focuses on evaluating innovative therapeutic interventions across the full spectrum of renal care, from severe CKD to dialysis and transplant populations.
- Cardiovascular and renal outcomes in severe chronic kidney disease (eGFR ≤25 mL/min/1.73m²)
- Novel SGLT2 inhibitor therapies in advanced nephrology populations
- Heart failure prevention and management in dialysis and kidney transplant patients
The center conducts pivotal research examining composite endpoints that matter most to patients, including kidney failure, cardiovascular hospitalizations, and mortality reduction. With expertise spanning dialysis patients and kidney transplant recipients with reduced eGFR, Elyse Klinieken voor Nierzorg plays a vital role in generating evidence for therapeutic strategies that address the complex interplay between renal and cardiovascular health in vulnerable patient populations with severe renal impairment.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 271 other sites in The Netherlands
Therapeutic Area Benchmark — The Netherlands
Select a therapeutic area to compare against other sites in The Netherlands.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: The Netherlands
Market Share
Country: The Netherlands
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Elyse klinieken voor nierzorg
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients with Severe Chronic Kidney Disease: A Randomized Controlled Trial | Universitair Medisch Centrum Groningen | Phase III | Recruiting | Nov 2022 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dapagliflozin | 1 | Unknown | 2022-11-08 | 2022-11-08 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.